The Journal of Tehran University Heart Center Gholamreza Davoodi et al. 66. 67. 68. 69. 70. Atherosclerotic peripheral vascular disease interdisciplinary working group; Cardiovascular nursing Council; clinical cardiology council; Nutrition, physical activity, and metabolism council; and the Quality of care and outcomes research interdisciplinary working group; the American academy of neurology affirms the value of this guideline. Stroke 2006;37:1583-1633. Nieuwlaat R, Prins MH, Le Heuzey JY, Vardas PE, Aliot E, Santini M, Cobbe SM, Widdershoven JW, Baur LH, Levy S, Crijns HJ. Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro heart survey on atrial fibrillation. Eur Heart J 2008;29:1181-1189. Thambidorai SK, Murray RD, Parakh K, Shah TK, Black IW, Jasper SE, Li J, Apperson-Hansen C, Asher CR, Grimm RA, Klein AL; ACUTE investigators. Utility of transesophageal echocardiography in identification of thrombogenic milieu in patients with atrial fibrillation (an ACUTE ancillary study). Am J Cardiol 2005;96:935-941. Kavlak ES, Kucukoglu H, Yigit Z, Okcun B, Baran T, Ozkan AA, Kucukoglu S. Clinical and echocardiographic risk factors for embolization in the presence of left atrial thrombus. Echocardiography 2007;24:515-521. Menke J, Lüthje L, Kastrup A, Larsen J. Thromboembolism in atrial fibrillation. Am J Cardiol 2010;105:502-510. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BS, Darius H, Diener HC, Joyner CD, Wallentin L; RE-LY steering committee and investigators. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009;361:1139-1151. 178